Annual CFF
$28.71 M
-$17.66 M-38.08%
31 March 2024
Summary:
LakeShore Biopharma annual cash flow from financing activities is currently $28.71 million, with the most recent change of -$17.66 million (-38.08%) on 31 March 2024. During the last 3 years, it has fallen by -$80.40 million (-73.69%). LSB annual CFF is now -73.69% below its all-time high of $109.11 million, reached on 01 March 2021.LSB Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$6.20 M
0.00%
30 September 2023
Summary:
LakeShore Biopharma quarterly cash flow from financing activities is currently $6.20 millionLSB quarterly CFF is now -18.20% below its all-time high of $7.58 million, reached on 01 September 2022.LSB Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$6.20 M
0.00%
30 September 2023
Summary:
LakeShore Biopharma TTM cash flow from financing activities is currently $6.20 millionLSB TTM CFF is now -18.20% below its all-time high of $7.58 million, reached on 01 September 2022.LSB TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LSB Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -38.1% | - | - |
| 3 y3 years | -73.7% | - | - |
| 5 y5 years | - | - | - |
LSB Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -73.7% | at low | -18.2% | at low | -18.2% | at low |
| 5 y | 5 years | -73.7% | at low | -18.2% | at low | -18.2% | at low |
| alltime | all time | -73.7% | at low | -18.2% | at low | -18.2% | at low |
LakeShore Biopharma Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | $28.71 M(-38.1%) | - | - |
| Sept 2023 | - | $6.20 M(-18.2%) | $6.20 M(-18.2%) |
| Mar 2023 | $46.37 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $7.58 M | $7.58 M |
| Mar 2022 | $56.75 M(-48.0%) | - | - |
| Mar 2021 | $109.11 M | - | - |
FAQ
- What is LakeShore Biopharma annual cash flow from financing activities?
- What is the all time high annual CFF for LakeShore Biopharma?
- What is LakeShore Biopharma annual CFF year-on-year change?
- What is LakeShore Biopharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for LakeShore Biopharma?
- What is LakeShore Biopharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for LakeShore Biopharma?
What is LakeShore Biopharma annual cash flow from financing activities?
The current annual CFF of LSB is $28.71 M
What is the all time high annual CFF for LakeShore Biopharma?
LakeShore Biopharma all-time high annual cash flow from financing activities is $109.11 M
What is LakeShore Biopharma annual CFF year-on-year change?
Over the past year, LSB annual cash flow from financing activities has changed by -$17.66 M (-38.08%)
What is LakeShore Biopharma quarterly cash flow from financing activities?
The current quarterly CFF of LSB is $6.20 M
What is the all time high quarterly CFF for LakeShore Biopharma?
LakeShore Biopharma all-time high quarterly cash flow from financing activities is $7.58 M
What is LakeShore Biopharma TTM cash flow from financing activities?
The current TTM CFF of LSB is $6.20 M
What is the all time high TTM CFF for LakeShore Biopharma?
LakeShore Biopharma all-time high TTM cash flow from financing activities is $7.58 M